DZ Bank Knock-Out GLJ/ DE000DFT3953 /
11/06/2024 12:06:48 | Diferencia+0.030 | Bid11/06/2024 | Ask11/06/2024 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.820EUR | +3.80% | 0.820 Volumen de oferta: 15,000 |
0.830 Tamaño/ Volumen/ Formato de Ask: 15,000 |
GRENKE AG NA O.N. | 12.7964 EUR | 31/12/2078 | Call |
GlobeNewswire
12:31
UIPATH NOTICE: If You Suffered Losses When UiPath, Inc.’s (NYSE: PATH) Stock Dropped 34%, You are Re...
GlobeNewswire
12:30
Park Hotels & Resorts Announces Second Quarter 2024 Earnings Conference Call on August 1, 2024
GlobeNewswire
12:30
Fastly ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Enco...
GlobeNewswire
12:28
CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Urg...
GlobeNewswire
12:00
Liberty Gold Announces Approval of the Fourth Plan of Operations Amendment, Black Pine Oxide Gold Pr...
GlobeNewswire
12:00
RadNet, Inc. to Present at the Sidoti & Company 2024 Small Cap Conference on Wednesday, June 12th
GlobeNewswire
12:00
SiteMinder and Cloudbeds partner to create new distribution and revenue opportunities for hotels
GlobeNewswire
12:00
Digihost Expands Bitcoin Mining Operations with 11,000 S21s Increasing Hashing Rate to 3.2 EH/s
GlobeNewswire
12:00
Kepler Validates SDA-Compatible Optical Technology For Space Data Relay Constellation
GlobeNewswire
12:00
FreedomPay Launches Industry’s First Independent Payment Processing Referral Advisory for Merchants
GlobeNewswire
12:00
Iveco Group signs a 150 million euro term loan facility with Cassa Depositi e Prestiti to support in...
GlobeNewswire
12:00
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página